What question did this study set out to answer?

To evaluate the associations between sMICA levels, lung cancer, and COPD risk factors.

February 16, 2026Open Access

Soluble Major Histocompatibility Complex I-Related Chain A (sMICA)*008 Levels Associate with Smoking, Presence of Chronic Obstructive Pulmonary Disease, and Prevalence of Lung Cancer

View Full Paper

Ask AI

Bookmark

Authors

Multivariate regression shows sMICA levels associate with lung cancer and COPD, highlighting its role as a biomarker.

To evaluate the associations between sMICA levels, lung cancer, and COPD risk factors.
Analyzed statistical associations between sMICA levels and demographic/clinical variables.
Utilized multivariate linear regression to assess relationships between sMICA levels and lung cancer histology.
Calculated point estimates and 95% confidence intervals for statistical interpretation.
sMICA levels higher in smokers compared to non-smokers.
NSCLC associated with significant increase in sMICA levels compared to non-cancer participants.
Primary lung cancer and COPD are independently linked to elevated sMICA levels.

Burkes et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark